Related Experiment Video

Updated: Aug 7, 2026

Ovariectomy and 17β-estradiol Replacement in Rats and Mice: A Visual Demonstration
06:51

Ovariectomy and 17β-estradiol Replacement in Rats and Mice: A Visual Demonstration

Published on: June 7, 2012

Estradiol prevents the injury-induced decrease of Akt/glycogen synthase kinase 3beta phosphorylation

Phil Ok Koh1, Chung Kil Won, Jae Hyun Cho

  • 1Department of Anatomy, College of Veterinary Medicine, Research Institute of Life Science, Gyeongsang National University, 900 Gajwa-dong, Jinju, South Korea. pokoh@gsnu.ac.kr

Neuroscience Letters
|July 4, 2006
PubMed

Insights

Estradiol protects brain cells from injury by activating survival signals. This hormone reduces stroke damage and cell death by phosphorylating Akt and GSK3beta, key proteins in cell survival pathways.

Area of Science:

  • Neuroscience
  • Endocrinology
  • Cell Biology

Background:

  • Estradiol is known to protect neurons from cell death.
  • The precise molecular mechanisms, particularly involving cell survival signaling pathways, require further elucidation.

Purpose of the Study:

  • To investigate if estradiol modulates anti-apoptotic signaling via the phosphorylation of Akt and glycogen synthase kinase 3beta (GSK3beta).
  • To determine the role of these signaling pathways in estradiol's neuroprotective effects against ischemic brain injury and glutamate toxicity.

Main Methods:

  • Ovariectomized adult female rats underwent middle cerebral artery occlusion (MCAO) with or without estradiol treatment.
  • Western blot analysis and immunohistochemistry were used to assess the phosphorylation of Akt and GSK3beta.
  • Glutamate toxicity assays were performed on hippocampal HT22 cells pretreated with estradiol.

Main Results:

  • Estradiol administration significantly reduced infarct volume and TUNEL-positive cells in the cerebral cortex after MCAO.
  • Estradiol prevented the decrease in phosphorylated Akt (pAkt) and phosphorylated GSK3beta (pGSK3beta) following MCAO.
  • In HT22 cells, estradiol reduced glutamate toxicity and prevented the decrease in pAkt and pGSK3beta.

Conclusions:

  • Estradiol exerts a potent neuroprotective effect against brain injury.
  • The phosphorylation of Akt and GSK3beta by estradiol is a key mechanism mediating these protective effects against ischemic injury and excitotoxicity.

More Related Videos

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause06:18

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on: August 13, 2019

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...